Bladder Cancer,Genitourinary Cancer Enfortumab Vedotin vs. Standard Chemotherapy for Advanced Urothelial Cancer: Phase 3 Results from EV-301 Apr 20, 2023
Colorectal Cancer,Gastrointestinal Cancer Enhancing Immunotherapy Efficacy in Metastatic Colorectal or NSCLC with Durvalumab and Tremelimumab: Phase II Study Apr 17, 2023
Colorectal Cancer,Gastrointestinal Cancer Phase 3 XELAVIRI Trial: Cap+Bev vs Cap+Iri+Bev 1st-line Therapy in mCRC Apr 17, 2023
Colorectal Cancer,Gastrointestinal Cancer Maya Phase 2 Study: Nivolumab Plus Ipilimumab and Temozolomide in Microsatellite Stable, MGMT Silenced mCRC Apr 17, 2023
Colorectal Cancer,Gastrointestinal Cancer CheckMate 8HW Phase 3 Study: Analyzing Immunotherapy and Chemotherapy for mCRC Apr 17, 2023
Colorectal Cancer,Gastrointestinal Cancer Regorafenib vs. Placebo for Metastatic Colorectal Cancer Treatment After Standard Therapy Failure Apr 17, 2023
Colorectal Cancer,Gastrointestinal Cancer STRATEGIC-1 Phase 3 Trial: Exploring the influence of age on treatment strategies for RAS/BRAF wild-type mCRC Apr 17, 2023
Colorectal Cancer,Gastrointestinal Cancer CALGB/SWOG 80405 Trial: Promising Results of Cetuximab and Bevacizumab in Colorectal Cancer Treatment Apr 17, 2023
